EC Gynaecology

Research Article Volume 15 Issue 11 - 2026

Prevalence of Trichomonas vaginalis and Associated Factors among Pregnant Women Attending Antenatal Care at Mattu Karl Specialized Hospital, Oromia Region, Southwest Ethiopia

Bikila Jiregna1* and Chaltu Hinkosa2

1Lecturer at Department of Midwifery College of Health Science, Mattu University, Oromia Region, Ethiopia 2Lecturer at School of Nursing and Midwifery, Institute of Health science, Wollega University, Oromia Region, Ethiopia

*Corresponding Author: Bikila Jiregna, Lecturer at Department of Midwifery College of Health Science, Mattu University, Oromia Region, Ethiopia.
Received: September 25, 2026; Published: November 03, 2026



Background: Trichomoniasis, caused by Trichomonas vaginalis, is a major curable infection globally, accounting for an estimated 276 million of the 499 million new curable STIs worldwide in 2018. In Ethiopia, genital infections during pregnancy cause significant health complications.

Objective: To assess the prevalence and associated factors of T. vaginalis among pregnant women attending antenatal care (ANC) at Mattu Karl Comprehensive Specialized Hospital, Southwest Ethiopia, 2025.

Methods: A facility-based cross-sectional study was conducted from March 10 to May 10, 2025, among 288 pregnant women selected via systematic random sampling. Data collected through pre-tested, interviewer-administered questionnaires were analyzed using SPSS version 26.0. Multicollinearity was evaluated using the variance inflation factor, and model fit was verified via the Hosmer and Lemeshow test. Adjusted odds ratios (AOR) with 95% confidence intervals (CI) and p-values < 0.05 determined statistical significance.

Results: With a 98.3% response rate, the overall prevalence of T. vaginalis was 10% (29/288; 95% CI: 8.23-12.43). Factors significantly associated with higher odds of infection included having two or more sexual partners (AOR = 4.56, 95% CI: 2.31-7.45), urban residence (AOR = 2.00, 95% CI: 1.19-4.23), and practicing vaginal douching once per day (AOR = 3.75, 95% CI: 1.87-5.98).

Conclusion: The prevalence of T. vaginalis among ANC attendees at Mattu Karl Comprehensive Specialized Hospital is substantial (10%). Routine screening for T. vaginalis should be integrated into standard laboratory protocols during routine antenatal care visits to mitigate maternal and neonatal complications

Keywords: Trichomonas vaginalis; Pregnant Women; Antenatal Care

  1. Shim BS. “Current concepts in bacterial sexually transmitted diseases”. Korean Journal of Urology 9 (2011): 589-597.
  2. Van Gerwen OT and Muzny CA. “Recent advances in the epidemiology, diagnosis, and management of Trichomonas vaginalis infection”. F1000Research 8 (2019): F1000 Faculty Rev-1666.
  3. Preethi V., et al. “Trichomoniasis: an update”. Tropical Parasitology2 (2011): 73-75.
  4. Güzel Y. “Overview of sexually transmitted infections”. Health Sciences Research in the Globalizing World (2018): 8.
  5. Schwebke JR and Burgess D. “Trichomoniasis”. Clinical Microbiology Reviews4 (2004): 794-803.
  6. Van Gerwen OT and Muzny CA. “Recent advances in the epidemiology, diagnosis, and management of Trichomonas vaginalis infection”. F1000Research 8 (2019): F1000 Faculty Rev-1666.
  7. Owowo E., et al. “Incidence of Trichomonas vaginalis among internally displaced women in Ibaka, Akwa Ibom State, Nigeria”. Journal of Biosciences and Medicines3 (2022): 82-89.
  8. Workowski KA., et al. “Sexually transmitted infections treatment guidelines, 2021”. MMWR Recommendations and Reports4 (2021): 1-187.
  9. Organization WH. “More than 1 million new curable sexually transmitted infections every day”. Geneva: World Health Organization (2019).
  10. Kreisel K., et al. “Prevalence of pelvic inflammatory disease in sexually experienced women of reproductive age - United States, 2013-2014”. Morbidity and Mortality Weekly Report 3 (2017): 80-83.
  11. Ginindza TG., et al. “Prevalence and risk factors associated with sexually transmitted infections (STIs) among women of reproductive age in Swaziland”. Infectious Agents and Cancer 12 (2017): 29.
  12. Tamir TT., et al. “Early neonatal mortality and determinants in sub-Saharan Africa: Findings from recent demographic and health survey data”. PLoS One 6 (2024): e0304065.
  13. Taha TE and Gray RH. “Genital tract infections and perinatal transmission of HIV”. Annals of the New York Academy of Sciences 1 (2000): 84-98.
  14. Negussie YM., et al. “Self-reported sexually transmitted infections and associated factors among sexually active men in East Africa: a multilevel analysis of recent demographic and health surveys”. BMJ Open1 (2025): e085628.
  15. Sangaré I., et al. “Prevalence and factors associated of Trichomonas vaginalis infection among pregnant women in Bobo-Dioulasso, Burkina Faso”. Annals of Parasitology2 (2021): 321-328.
  16. Gatti FAdA., et al. “The prevalence of trichomoniasis and associated factors among women treated at a university hospital in southern Brazil”. PLoS One3 (2017): e0173604.
  17. Auta I., et al. “Prevalence of Trichomonas vaginalis among pregnant women attending antenatal clinic in two health facilities within Kaduna metropolis, Kaduna, Nigeria”. Science World Journal1 (2020): 97-101.
  18. Oyeyemi OT., et al. “Trichomonas vaginalis infection in Nigerian pregnant women and risk factors associated with sexually transmitted infections”. International Journal of STD and AIDS 13 (2016): 1187-1193.
  19. Etuketu MI., et al. “Prevalence and risk factors of Trichomonas vaginalis infection among pregnant women receiving antenatal care in Abeokuta, Nigeria”. African Journal of Infectious Diseases2 (2015): 51-56.
  20. Mabaso N., et al. “Prevalence and risk factors for Trichomonas vaginalis infection in pregnant women in South Africa”. International Journal of STD and AIDS4 (2020): 351-358.
  21. Husen O., et al. “Trichomonas vaginalis and associated factors among pregnant women attending antenatal care at Bule Hora university teaching hospital, Oromia region, Southern Ethiopia”. Journal of Parasitology Research 1 (2023): 4913058.
  22. Regassa BT., et al. “Prevalence of bacterial vaginosis and its associated factors among pregnant women attending antenatal care clinics at public hospitals in West Shoa Zone, Oromia, Ethiopia”. Scientific Reports1 (2024): 21474.
  23. Zenebe M., et al. “P140 Prevalence, risk factors and association with delivery outcome of curable sexually transmitted infections among pregnant women in Southern Ethiopia”. BMJ Publishing Group Ltd (2021).
  24. Wireko S., et al. “Vaginal douching and health risks among young women”. Health Science Reports 2 (2024): e1882.
  25. Mulugeta Animaw AA., et al. “Knowledge, attitude and practice towards obstetric danger signs during pregnancy among women attending antenatal care at Mettu Karl Referal Hospital, Ilu-Ababore Zone, Southwest Ethiopia 2021”. Journal of Women Health Care and Gynecology1 (2025): 25.
  26. Cheesbrough M. “District laboratory practice in tropical countries, part 2”. Cambridge: Cambridge University Press (2006).
  27. Khatoon R., et al. “Evaluation of different staining techniques in the diagnosis of Trichomonas vaginalis infection in females of reproductive age group”. Journal of Clinical and Diagnostic Research: JCDR 12 (2014): DC05-DC08.
  28. Hanlon C., et al. “Detecting perinatal common mental disorders in Ethiopia: validation of the self-reporting questionnaire and Edinburgh Postnatal Depression Scale”. Journal of Affective Disorders3 (2008): 251-262.
  29. Ijasan O., et al. “The prevalence and risk factors for Trichomonas vaginalis infection amongst human immunodeficiency virus-infected pregnant women attending the antenatal clinics of a university teaching hospital in Lagos, South-Western, Nigeria”. Nigerian Postgraduate Medical Journal1 (2018): 21-26.
  30. Ambrozio CL., et al. “Trichomonas vaginalis prevalence and risk factors for women in southern Brazil”. Revista do Instituto de Medicina Tropical de São Paulo 58 (2016): 61.
  31. Dev R., et al. “Prevalence assessment of sexually transmitted infections among pregnant women visiting an antenatal care center of Nepal”. Plos one4 (2021): e0250361.
  32. Adjei C., et al. “Prevalence and the evaluation of culture, wet mount, and ELISA methods for the diagnosis of Trichomonas vaginalis infection among Ghanaian women using urine and vaginal specimens”. Tropical Medicine and Health 47 (2019): 33.
  33. Akinbo FO., et al. “Prevalence of trichomoniasis among pregnant women in Benin City”. Sahel Medical Journal2 (2017): 67-71.
  34. De Waaij DJ., et al. “Prevalence of Trichomonas vaginalis infection and protozoan load in South African women: a cross-sectional study”. BMJ Open10 (2017): e016959.
  35. Silva J., et al. “Prevalence of Neisseria gonorrhoeae and Trichomonas vaginalis in Portuguese women of childbearing age”. Journal of Obstetrics and Gynaecology 2 (2021): 254-258.
  36. Al-Mekhlafi AM and Al-Eryani SM. “Prevalence and risk factors for Trichomonas vaginalis infection among pregnant women seeking primary health care in Sana'a city, Yemen”. Yemeni Journal for Medical Sciences1 (2017): 8-14.
  37. Eshete A., et al. “Trichomonas vaginalis infection among pregnant women in Jimma University Specialized Hospital, Southwest Ethiopia”. ISRN Infectious Diseases (2013): 1-7.
  38. Shayo PA., et al. “Prevalence of bacterial vaginosis and associated factors among pregnant women attending at Bugando Medical Centre, Mwanza, Tanzania”. Tanzania Journal of Health Research3 (2012): 175-182.
  39. Martino JL and Vermund SH. “Vaginal douching: evidence for risks or benefits to women's health”. Epidemiologic Reviews 2 (2002): 109-124.
  40. Brotman RM., et al. “The effect of vaginal douching cessation on bacterial vaginosis: a pilot study”. American Journal of Obstetrics and Gynecology6 (2008): 628.e1-e7.
  41. Johnston VJ and Mabey DC. “Global epidemiology and control of Trichomonas vaginalis”. Current Opinion in Infectious Diseases1 (2008): 56-64.
  42. Rowley J., et al. “Chlamydia, gonorrhoea, trichomoniasis, and syphilis: global prevalence and incidence estimates, 2016”. The Lancet Global Health8 (2019): e1009-e1031.
  43. McClelland RS., et al. “Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition”. The Journal of Infectious Diseases5 (2007): 698-702.
  44. Laga M., et al. “Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study”. AIDS 1 (1993): 95-102.
  45. Poole DN and McClelland RS. “Global epidemiology of Trichomonas vaginalis”. Sexually Transmitted Infections 6 (2013): 418-422.
  46. Hook EW. “Trichomonas vaginalis—no longer a minor STI”. Sexually Transmitted Diseases 7 (1999): 390-391.
  47. Silver BJ., et al. “Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis”. Sexually Transmitted Diseases6 (2014): 369-376.
  48. Ness RB., et al. “Douching in relation to bacterial vaginosis, common pelvic infections, and sexually transmitted diseases”. American Journal of Epidemiology3 (2002): 273-282.
  49. Cottrell BH. “An updated review of vaginal douching”. Journal of Obstetric, Gynecologic, and Neonatal Nursing1 (2010): 85-97.

Bikila Jiregna and Chaltu Hinkosa. “Prevalence of Trichomonas vaginalis and Associated Factors among Pregnant Women Attend- ing Antenatal Care at Mattu Karl Specialized Hospital, Oromia Region, Southwest Ethiopia”. EC Gynaecology 15.11 (2026): 01-14.

ECronicon Journal

Our Services

Quick Links

Information

Creative Commons LicenseOpen Access by ECronicon is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at www.ecronicon.net